- 24/7 Wall St.•last month
Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.
It doesn't require any ammo or power supply. It's a dead-simple survival and self-defence tool, but don't underestimate how useful it is when needed.
- Capital Cube•2 months ago
Click here to see latest analysisCapitalcube gives Insulet Corp. a score of 34.Our analysis is based on comparing Insulet Corp. with the following peers – ICU Medical, Inc., Unilife Corporation, Delcath Systems, Inc., Tandem Diabetes Care, Inc., DexCom, Inc., Medtronic Plc, Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson and Echo Therapeutics, Inc. (ICUI-US, […] (Read more...) The post Insulet Corp. – Value Analysis (NASDAQ:PODD) : June 8, 2016 appeared first on CapitalCube.
After hours: 34.790.00 (0.00%) as of 4:44 PM EDT
|Bid||34.79 x 2000|
|Ask||34.81 x 3000|
|52wk Range||23.94 - 40.21|
|Day's Range||32.50 - 34.92|
|Avg Vol (3m)||669,158|
As of 4:00 PM EDT. Market closed.